MTAP and neoplasm: Future mechanistic studies are warranted to define how MTAP deficiency alters tumor glutamate metabolism to suppress CXCL10 expression, and whether CB-839-mediated upregulation of CXCL10 is sufficient to restore T cell infiltration and activation in MTAP-deficient tumors.